PEC Ltd. US$160 million buyout and privatization by Liberty Energy Solutions Ltd

SINGAPORE, May 7, 2025 /PRNewswire/ — PEC Ltd ("PEC", SGX: IX2) shareholders…

"Human Creativity is Inspired by Abstract Connections That AI Cannot Intuitively Make"

The Orangeblowfish Creative Agency Founder to Join Dynamic Panel at Design Shanghai…

SGS & Co and SGK unite to become Propelis – a global agency built for brand impact

Propelis family of brands created to serve wide range of client needs…

Lake Resources Announces Exploration of Strategic Alternatives

SYDNEY, May 7, 2025 /PRNewswire/ — Lake Resources N.L. (ASX: LKE; OTC: LLKKF)…

FancyTech Closes Series B+ to Power AI Personalized Content Solutions in Thailand and Southeast Asia

BANGKOK, May 7, 2025 /PRNewswire/ — FancyTech, an AI startup specializing in…

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs…

Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema

SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ — Innovent Biologics,…

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

SUZHOU, China, May 7, 2025 /PRNewswire/ — CStone Pharmaceuticals ("CStone", HKEX: 2616), an…